VPS41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.106000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.818200E-01
Normal-vs-Stage2
1.145610E-01
Normal-vs-Stage3
7.817900E-02
Normal-vs-Stage4
9.545600E-01
Stage1-vs-Stage2
8.892400E-01
Stage1-vs-Stage3
7.141600E-02
Stage1-vs-Stage4
1.773550E-01
Stage2-vs-Stage3
9.454000E-02
Stage2-vs-Stage4
5.198100E-02
Stage3-vs-Stage4
3.346200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.879230E-01
Normal-vs-AfricanAmerican
4.529400E-01
Normal-vs-Asian
2.411400E-01
Caucasian-vs-AfricanAmerican
6.403800E-01
Caucasian-vs-Asian
5.905000E-01
AfricanAmerican-vs-Asian
5.080800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.534410E-01
Normal-vs-Female
3.039400E-01
Male-vs-Female
5.011200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.168000E-01
Normal-vs-Age(41-60Yrs)
4.705400E-01
Normal-vs-Age(61-80Yrs)
1.535830E-01
Normal-vs-Age(81-100Yrs)
9.658100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.359200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.470400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.371400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.004200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.916300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.151800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.104200E-02
Normal-vs-Daily Drinker
1.693800E-02
Normal-vs-Weekly Drinker
1.836620E-01
Normal-vs-Occasional Drinker
9.863400E-01
Normal-vs-Social Drinker
4.021200E-01
Non Drinker-vs-Daily Drinker
4.002200E-01
Non Drinker-vs-Weekly Drinker
7.431600E-01
Non Drinker-vs-Occasional Drinker
3.969800E-02
Non Drinker-vs-Social Drinker
1.295560E-01
Daily Drinker-vs-Weekly Drinker
2.841400E-01
Daily Drinker-vs-Occasional Drinker
1.412240E-02
Daily Drinker-vs-Social Drinker
1.976070E-02
Weekly Drinker-vs-Occasional Drinker
8.190400E-02
Weekly Drinker-vs-Social Drinker
3.253200E-01
Occasional Drinker-vs-Social Drinker
2.838600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.866790E-01
Normal-vs-Grade 2
1.473650E-02
Normal-vs-Grade 3
1.875910E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.314400E-01
Grade 1-vs-Grade 3
9.670000E-01
Grade 1-vs-Grade 4
1.866790E-01
Grade 2-vs-Grade 3
1.115760E-01
Grade 2-vs-Grade 4
1.473650E-02
Grade 3-vs-Grade 4
1.875910E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.565990E-01
Normal-vs-NonDiabetic
2.207400E-01
Diabetic-vs-NonDiabetic
4.529000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.881000E-01
Normal-vs-NoPancreatitis
2.475000E-01
Pancreatitis-vs-NoPancreatitis
2.313700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.567600E-01
Normal-vs-N1
1.346190E-01
N0-vs-N1
6.984800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.806390E-01
Normal-vs-TP53-NonMutant
3.997000E-01
TP53-Mutant-vs-TP53-NonMutant
7.246400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
